The seroepidemiology of tetanus in Catalonia, Spain

Àngela Domı́nguez1, Pere Plans1, Josep Costa2, Jordi Espuñes1, Neus Cardeñosa1, L. Salleras3, Antoni Plasència1
1General-Directorate of Public Health, Generalitat of Catalonia, Barcelona, Spain
2Microbiology Laboratory, Hospital Clínic, Barcelona, Spain
3Department of Public Health, University of Barcelona, Barcelona, Spain

Tóm tắt

Từ khóa


Tài liệu tham khảo

Amela C, Pachón I (2000) Estudio seroepidemiológico: situación de las enfermedades vacunables en España. Instituto de salud Carlos III, Madrid

Aue A, Hennig H, Krüger S, Closius B, Kirchner H, Seyfarth M (2003) Immunity against diphtheria and tetanus in German blood donors. Med Microbiol Immunol 192:93–97

Bardenheier B, Prevots DR, Khetsuriani N, Wharton M (1998) Tetanus surveillance—United States, 1995–1997. Centers for Disease Control and Prevention. MMWR Surveill Summ 47:1–13

Bayas JM, Vilella A, Bertran MJ, Vidal J, Batalla J, Asenjo MA, Salleras L (2001) Immunogenecity and reactogenecity of the adult tetanus-diphtheria vaccine. How many doses are necessary? Epidemiol Infect 127:451–460

Black TP (2005) Clostridium tetani (Tetanus). In: Mandel GL, Bennelt JE, Dolin R (eds) Principles and practice of infectious diseases, 6th edn. Elsevier/Churchill Livingstone, Philadelphia, pp 2817–2822

Bonetti TCS, Succi RCM, Wechx LY, Tavares-Lopez L, de Moraes-Pinto MI (2004) Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1-infected women. Vaccine 22:3707–3712

Caglar K, Karakus R, Aybay C (2005) Determination of tetanus antibodies by a double-antigen enzyme-linked immunosorbent assay in individuals of various age groups. Eur J Clin Microbiol Infect Dis 24:523–528

Carson PJ, Nichol KL, O’Brien J, Hilo P, Janoff EN (2000) Immune function and vaccine responses in healthy advanced elderly patients. Arch Intern Med 160:2017–2024

Cavuslu S, Oncul O, Altunay H, Ozsoy MF, Kocak N (2003) Seroprevalence of tetanus antibody in Turkish population and effectiveness of single-dose tetanus toxoid. Eur J Clin Microbiol Infect Dis 22:431–433

Centers for Disease Control and Prevention (2006) Recommended childhood and adolescent immunization schedule—United States, 2006. MMWR 54:Q1–Q4

Centers for Disease Control, Prevention (2005) Recommended adult immunization schedule—United States, 2005—September 2006. MMWR 54:Q1–Q4

Centro Nacional de Epidemiología (2005) Comentario epidemiológico de las enfermedades de declaración obligatoria y sistema de información microbiológica. Boletín Epidemiológico Semanal 13:109–116

Cohen AL, Veenstra D (2006) Economic analysis of prevaccination serotesting compared with presumptive immunization for polio, diphtheria, and tetanus in internationally adopted and immigrant infants. Pediatrics 117:1650–1655

De Melker HE, Van Den Hof S, Berbers GA, Conyn-van Spaendonck MA (2003) Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b. Vaccine 21:716–720

Dening MS, Roungou JB, Kristiansen M, Heron I, Yango A, Guenengafo A, Ndamobissi R (2002) Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus. Bull World Health Organ 80:696–703

Departamento de Salud (2005) Resumen de las enfermedades de declaración obligatoria en Cataluña durante el año 2004. Butlletí Epidemiològic de Catalunya XXVI:145–157

Dundar V, Yumuk Z, Ozturk-Dundar D, Erdogan S, Gacar G (2005) Prevalence of tetanus immunity in the Kocaeli Region, Turkey. Jpn J Infect Dis 58:279–282

Gidding HF, Backhouse JL, Burgess MA, Gilbert GL (2005) Immunity to diphtheria and tetanus in Australia: a national serosurvey. Med J Aust 183:301–304

Hayney MS, Love GD, Carlberg BM, Muller D (2003) Tetanus seroprevalence among farmers: a preliminary study. J Rural Health 19:109–112

Heyman DL (ed) (2004) Control of communicable disease manual, 18th edn. American Public Health Association, Washington, pp 528–534

Hüllstrung HD, Mäusezahl D, Feuz M. Herzog C, Conzelmann M, Zimmerli W (2003) Tetanus immunisation in geriatric patients with accidental wounds: how much is needed? Swiss Med Wkly 133:227–232

Inandi T, Ertekin V, Ayyildiz A (2002) Sero-epidemiology of tetanus antibody among the children in eastern Turkey. Public Health 116:379–382

Institut d’Estadística de Catalunya (2002) Anuari d’estadística 2001, Barcelona: Institut d’Estadística de Catalunya

Janout V, Matouskova I, Cizek L (2003) The 2001 serologic survey in the Czech Republic tetanus. Cent Eur J Public Health 11(Suppl):S13–S16

Kiliç D, Kaygusuz S, Saygun M, Çakmak A, Uzer H, Doganci L (2003) Seroprevalence of tetanus immunity among noninsulin-dependent diabetes mellitus patients. J Diabetes Complicat 17:258–263

Kurtoglu D, Gozalan A, Coplu N, Miyamurc K, Morita M, Egen B, Akin L (2004) Community-based seroepidemiology of tetanus in three selected provinces in Turkey. Jpn J Infect Dis 57:10–16

Maple PAC, Jones CS, Wall EC, Vyse E, Edmunds WJ, Andrews NJ, Miller E (2001) Immunity to diphtheria and tetanus in England and Wales. Vaccine 19:167–173

McQuillan GM, Kruszon-Moran D, Deforest A, Chu SY, Wharton M (2002) Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med 136:660–666

Mendrinou E, Konzelis A, Georgakapoulos P, Dodou V, Regli A (2004) Immunity to tetanus of a rural population in a Greek country. New Microbiol 27:187–189

Office of population censures and surveys (1980) Classification of occupations. OPSC, London

Pachón I, Amela C, de Ory F (2002) Age-specific seroprevalence of poliomyelitis, diphtheria and tetanus antibodies in Spain. Epidemiol Infect 129:535–541

Redwan El-RM, Al-Awady MK (2002) Prevalence of tetanus immunity in the Egyptian population. Hum Antibodies 11:55–59

Salleras L, Vidal J, Bruguera M, Gené J, Navas E, Batalla J, Bayas JM, Esteban R (1994) Vacunaciones del adulto. Med Clin (Barc) 102(Supl 1):42–55

Sauerbrei A, Groh A, Bischoff A, Prager J, Wutzler P (2002) Antibodies against vaccine-preventable diseases in pregnant women and their offspring in the eastern part of Germany. Med Microbiol Immunol (Berl) 190:167–172

Tamer A, Karabay O, Ekerbicer H, Tahtaci M, Selam B, Celebi H (2005) Impaired immunity against tetanus in type 2 diabetes. Med Sci Monit 11:CR580–CR584

Velarde C, Cordero AI, Elesh A, Gómez JA (2004) El reto de la protección antitetánica en los ancianos. Aten Primaria 33:524–525

Vidal J, Domínguez A, Plans P, Salleras L (2000) Seroepidemiología del tétanos en la población adulta de Cataluña, 1989–1996. Vacunas 1:153–156

Walory J, Grzesiowski P, Hryniewicz W (2000) Immunity against diphtheria and tetanus in the adult Polish population. Pol Merkuriusz Lek 9:687–692

Wassilak SG, Roper MH, Murphy TV, Orenstein WA (2004) Tetanus Toxoid. In: Plotkin SA, Orenstein WA (eds) Vaccines, 4th edn. Saunders, Philadelphia, pp 745–781